TP53 and lymphoma: The net results of the unique CX-5461-mediated unique DNA damage response is replication stress, leading to replication-dependent DNA damage and cell cycle arrest and cell death.43,294 The combination of CX-5461 with dual inhibition of CHK1/2 has been reported to significantly enhance the therapeutic outcome against p53-null MYC-driven lymphoma in vivo.36